Key points from article :
Researchers at The University of Queensland (UQ) have launched what they describe as the world’s first clinical trial of a wearable robotic exoskeleton designed specifically for people living with motor neuron disease (MND). Led by Associate Professor Dr Taylor Dick as part of the ALS Association–funded iMOVE-MND project, the trial aims to help people with MND walk for longer periods while reducing fatigue, potentially preserving mobility and independence as the disease progresses. The work has not yet been published in a scientific journal and is being reported as an early-stage clinical and engineering advance.
The lightweight, untethered exoskeleton is worn around the waist and lower legs and uses small motors and sensors to assist ankle movement during walking. By detecting forces through the foot, the device provides step-by-step support for key ankle motions needed to walk. A companion mobile app allows users and researchers to monitor and adjust assistance. According to Dr James Williamson, a postdoctoral fellow at UQ leading the device’s technical development, the goal is to help users take more steps each day while minimising physical exhaustion.
A second-generation version of the exoskeleton is now being tested, incorporating user feedback, improved sensors, and machine-learning algorithms that tailor assistance to each individual and adapt to different walking environments. Future versions may even allow voice control, making the system easier to use for people with limited hand function. The team also plans longer-term testing using detailed 3D gait analysis to track how the device performs as MND advances.
While robotic exoskeletons are already used in rehabilitation for stroke and injury, the UQ team is applying the technology in a new way—supporting ongoing mobility rather than short-term recovery. The researchers say close collaboration with the MND community will be essential to making the technology practical and accessible, as part of broader efforts that include UQ’s newly established Centre for Motor Neurone Disease Research.
